Clinical Trials List
Protocol NumberTLC388.4
2013-08-01 - 2015-12-31
Phase II
Terminated1
-
Trial Applicant
TAIWAN LIPOSOME CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- YU-YUN SHAO Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
53 participants
-
Global
53 participants
